These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Federici A; Marinacci C; Mangia M; Borgia P; Giorgi Rossi P; Guasticchi G Cancer Detect Prev; 2006; 30(4):347-53. PubMed ID: 16965874 [TBL] [Abstract][Full Text] [Related]
3. Screening for colorectal cancer using the faecal occult blood test, hemoccult. Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760 [TBL] [Abstract][Full Text] [Related]
4. Planning for a possible national colorectal cancer screening programme. Garvican L J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649 [TBL] [Abstract][Full Text] [Related]
5. Prevention of colorectal cancer by once-only sigmoidoscopy. Atkin WS; Cuzick J; Northover JM; Whynes DK Lancet; 1993 Mar; 341(8847):736-40. PubMed ID: 8095636 [TBL] [Abstract][Full Text] [Related]
6. Prospects for the secondary prevention of colorectal cancer: screening by flexible sigmoidoscopy? Woodman CB; Prior P; Joseph R; Watson A J Med Screen; 1995; 2(2):71-8. PubMed ID: 7497159 [TBL] [Abstract][Full Text] [Related]
7. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT). Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594 [TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Brevinge H; Lindholm E; Buntzen S; Kewenter J Int J Colorectal Dis; 1997; 12(5):291-5. PubMed ID: 9401844 [TBL] [Abstract][Full Text] [Related]
9. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. Lieberman DA; Weiss DG; N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208 [TBL] [Abstract][Full Text] [Related]
10. Limitations of the faecal occult blood test in screening for colorectal cancer. Delcò F; Sonnenberg A Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196 [TBL] [Abstract][Full Text] [Related]
11. Recent developments in colorectal cancer screening and prevention. Pignone M; Levin B Am Fam Physician; 2002 Jul; 66(2):297-302. PubMed ID: 12152966 [TBL] [Abstract][Full Text] [Related]
12. Colonoscopy as a mass screening tool. Lieberman D Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):225-8. PubMed ID: 9585025 [TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening. Bond JH Curr Opin Oncol; 1998 Sep; 10(5):461-6. PubMed ID: 9800118 [TBL] [Abstract][Full Text] [Related]
15. Should we be screening for colorectal cancer? Robinson MH; Hardcastle JD Br Med Bull; 1998; 54(4):807-21. PubMed ID: 10367416 [TBL] [Abstract][Full Text] [Related]
16. Significance of distal polyps detected with flexible sigmoidoscopy in asymptomatic patients. Matter SE; Campbell DR Arch Intern Med; 1992 Sep; 152(9):1776-80. PubMed ID: 1520044 [TBL] [Abstract][Full Text] [Related]
17. Screening guidelines for colorectal cancer. Bond JH Am J Med; 1999 Jan; 106(1A):7S-10S. PubMed ID: 10089107 [TBL] [Abstract][Full Text] [Related]
18. Screening for colorectal cancer. Use of a new protocol may reduce death rates. Lush DT Postgrad Med; 1994 Jul; 96(1):99-106. PubMed ID: 8022720 [TBL] [Abstract][Full Text] [Related]